Related Experiment Video
Updated: Aug 7, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Abstract:
Data from a preclinical study suggest rethinking the "oncometabolite hypothesis," which calls for blocking the product of neomorphic IDH1/2 mutations to halt tumor progression. Instead, exploiting the vulnerability of IDH1/2-mutant tumor cells to PARP inhibition, as a result of defective DNA repair, appears to be a more effective strategy that will soon be tested in the clinic.
Insights
Blocking IDH1/2 mutations may not be the best cancer strategy. Instead, targeting DNA repair defects in IDH1/2-mutant tumors with PARP inhibitors shows promise for halting tumor progression.
Area of Science:
- Oncology
- Cancer Genetics
- DNA Repair
Background:
- The oncometabolite hypothesis suggests blocking neomorphic IDH1/2 mutations halts tumor progression.
- IDH1/2 mutations are common in various cancers, driving tumorigenesis through altered metabolism.
Purpose of the Study:
- To evaluate alternative therapeutic strategies for IDH1/2-mutant tumors.
- To investigate the efficacy of PARP inhibition in IDH1/2-mutant cancer cells.
Main Methods:
- Preclinical study utilizing IDH1/2-mutant cancer models.
- Assessment of tumor cell vulnerability to PARP inhibition.
- Analysis of DNA repair mechanisms in IDH1/2-mutant cells.
Main Results:
- Data suggest that the oncometabolite hypothesis may require reevaluation.
- IDH1/2-mutant tumor cells exhibit a vulnerability to PARP inhibition.
- This vulnerability stems from defective DNA repair pathways.
Conclusions:
- Targeting DNA repair defects via PARP inhibition is a potentially more effective strategy than blocking IDH1/2 mutation products.
- This approach exploits a specific vulnerability of IDH1/2-mutant tumors.
- Clinical trials are anticipated to test this novel therapeutic strategy.
Related Concept Videos
Mismatch Repair
Nucleotide Excision Repair
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

